#GBPUSD

UK Q2 2026 GDP grew 0.5% (revised up 0.1pp), following 0.6% growth in Q1 2026.

#C_MCD

McDonald's (NYSE: MCD) recent sell-off looks more like a buying opportunity than a reason to avoid the stock.

#NFP Day – Oct 2

USD near 18-month highs (DXY ~102). NFP due 12:30 UTC, forecast +90K (prev +162K). Soft number: USD profit-taking. Strong beat: USD rally, EURUSD lower.

#S_LOW

Home-improvement retailer with soft housing/DIY demand. Stock down ~25% year-over-year to ~$182–185. Value supported by solid free cash flow, ~2.7% dividend yield, and ~15x P/E, though growth is capped until housing recovers. Analysts project upside to ~$250.

#L_AZN (AstraZeneca) – Short Fundamental

Price: ~11812
Forward P/E: ~14–15
Dividend yield: ~2%
Strong oncology portfolio + solid pipeline
Consensus: Strong Buy
Avg. target: ~15000_16000 (+25–35% upside)

#A_FMG (Fortescue) – Short Fundamental

Price: ~A$16.20–16.40
Trailing P/E: ~12x
Forward P/E: ~14x
Dividend yield: ~6.5% (high)
Analyst consensus: Hold
Average target: ~A$17.30–17.40 (+7–8% upside)

Key points:
Major iron ore producer. High dividend is attractive, but earnings are expected to decline with softer iron ore prices. Valuation is reasonable but not cheap given the cyclical risks.

Bottom line:
Good for income, but limited growth. Suitable only if you are bullish on iron ore prices.

#D_ADS (Adidas) – Short Fundamental

Price: ~€145
Trailing P/E: ~18–19x
Forward P/E: ~13–15x
Dividend yield: ~1.9–2.0%
Analyst consensus: Buy
Average target: ~€196–200 (+35% upside)

Key points:
Brand is recovering with improving sales momentum, especially in key markets. Margins are expanding and growth outlook is solid. Valuation looks reasonable given the recovery potential.

Bottom line:
Attractive recovery play in the sportswear sector. Good risk/reward at current levels for medium-term.